Back
Milestone Pharmaceuticals Vs. Triumph Financial Industry Stock Comparison
Sell
41
MIST
Milestone Pharmaceuticals
Last Price:
$2.25
Seasonality Move:
-15.15%
Sell
33
TFIN
Triumph Financial
Last Price:
$61.27
Seasonality Move:
-3.86%
Sell
41
Milestone Pharmaceuticals (MIST)
is a Sell
Is Milestone Pharmaceuticals a Buy, Sell or Hold?
-
The current Milestone Pharmaceuticals [MIST] share price is $2.01. The Score for MIST is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Triumph Financial (TFIN)
is a Sell
Is Triumph Financial a Buy, Sell or Hold?
-
The current Triumph Financial [TFIN] share price is $62.95. The Score for TFIN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
TFIN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MIST Stock Price Chart
What is Milestone Pharmaceuticals's stock price today?
-
The Milestone Pharmaceuticals share price today is $2.01Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIST is experiencing slight buying pressure.
TFIN Stock Price Chart
What is Triumph Financial's stock price today?
-
The Triumph Financial share price today is $62.95Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TFIN is experiencing selling pressure, which indicates risk of future bearish movement.
MIST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 50.61 | Buy |
Chaikin Money Flow: | 1434393 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.76 - 2.16) | Buy |
Bollinger Bands (100): | (1.72 - 2.14) | Buy |
TFIN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.79 | Sell |
Relative Strength Index (14 RSI): | 41.23 | Sell |
Chaikin Money Flow: | -133433 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (60.58 - 68.5) | Sell |
Bollinger Bands (100): | (70.03 - 99.47) | Sell |
MIST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.07 | Sell |
20-day SMA: | 1.93 | Buy |
50-day SMA: | 2.01 | Sell |
200-day SMA: | 1.69 | Buy |
8-day EMA: | 2 | Buy |
20-day EMA: | 2 | Buy |
50-day EMA: | 1.99 | Buy |
200-day EMA: | 1.88 | Buy |
TFIN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.4 | Buy |
20-day SMA: | 63.12 | Sell |
50-day SMA: | 72.56 | Sell |
200-day SMA: | 83.27 | Sell |
8-day EMA: | 62.79 | Buy |
20-day EMA: | 64.31 | Sell |
50-day EMA: | 71.39 | Sell |
200-day EMA: | 79.85 | Sell |
Milestone Pharmaceuticals Earnings Growth & MIST Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.36 per share.
Triumph Financial Earnings Growth & TFIN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.10 per share, an increase this year of $0.38 per share, and an increase next year of $1.38 per share.
Milestone Pharmaceuticals Technical Analysis
Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Triumph Financial Technical Analysis
Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |